Phase Ib study of selinexor and eribulin combination in advanced solid tumors and triple-negative breast cancer
Nelson, Blessie Elizabeth, Saleem, Sadia, Damodaran, Senthil, Somaiah, Neeta, Piha-Paul, Sarina Anne, Moore, Julia Ann, Yilmaz, Bulent, Karp, Daniel D., Dumbrava, Ecaterina Elena, Tsimberidou, Apostolia Maria, Hong, David S., Rodon Ahnert, Jordi, Booser, Daniel J., Ibrahim, Nuhad K., Conley, Anthony Paul, Bhosale, Priya, Rojas Hernandez, Cristhiam Mauricio, Tripathy, Debu, Naing, Aung, Meric-Bernstam, Funda
Published in Journal of clinical oncology (01.06.2022)
Published in Journal of clinical oncology (01.06.2022)
Get full text
Journal Article
Phase 1b study of combined selinexor and eribulin for the treatment of advanced solid tumors and triple‐negative breast cancer
Nelson, Blessie Elizabeth, Saleem, Sadia, Damodaran, Senthil, Somaiah, Neeta, Piha‐Paul, Sarina, Moore, Julia Ann, Yilmaz, Bulent, Ogbonna, Deby, Karp, Daniel D., Dumbrava, Ecaterina, Tsimberidou, Apostolia M., Hong, David S., Rodon Ahnert, Jordi, Milton, Denái R., Zheng, Xiaofeng, Booser, Daniel J., Ibrahim, Nuhad K., Conley, Anthony P., Bhosale, Priya, Rojas Hernandez, Cristhiam M., Tripathy, Debasish, Naing, Aung, Meric‐Bernstam, Funda
Published in Cancer (15.07.2023)
Published in Cancer (15.07.2023)
Get full text
Journal Article